AGP Picks
View all

Nevada Tech Journal
Provided by AGP

Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 4, 2026

Visionet Showcases AI-Driven Enterprise Transformation at ServiceNow Knowledge 2026
May 4, 2026

Visionet Showcases AI-Driven Enterprise Transformation at ServiceNow Knowledge 2026

Indeterminate EIN Presswire
MAU Vegas 2026 Brings Together the Builders of What Comes Next in Mobile Growth
May 4, 2026

MAU Vegas 2026 Brings Together the Builders of What Comes Next in Mobile Growth

Indeterminate EIN Presswire
P3 Group and Ottawa Infotainment Announce Strategic Collaboration at ACT Expo 2026
May 4, 2026

P3 Group and Ottawa Infotainment Announce Strategic Collaboration at ACT Expo 2026

Indeterminate EIN Presswire
Axiant Launches with Innovative Process-First Methodology to Address Automation Failures
May 4, 2026

Axiant Launches with Innovative Process-First Methodology to Address Automation Failures

Indeterminate GlobeNewswire
SCCG Management Appoints Ivo Dimitrov as Vice President of Strategy and Operations
May 4, 2026

SCCG Management Appoints Ivo Dimitrov as Vice President of Strategy and Operations

Indeterminate EIN Presswire
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
May 4, 2026

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study

Indeterminate GlobeNewswire
NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU
May 4, 2026

NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU

Indeterminate GlobeNewswire
Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities
May 4, 2026

Edgesource Corporation Acquires Lyteworx Automation Systems, Deepening Its Defense and Intelligence Mission Capabilities

Indeterminate GlobeNewswire
JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering
May 4, 2026

JIADE LIMITED Announces Pricing of up to $12.0 Million Registered Direct Offering

Indeterminate GlobeNewswire
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
May 4, 2026

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

Indeterminate GlobeNewswire
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Teva to Present at the BofA Securities Health Care Conference
May 4, 2026

Teva to Present at the BofA Securities Health Care Conference

Indeterminate GlobeNewswire
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 4, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Cellectis to Report First Quarter Financial Results on May 11, 2026
May 4, 2026

Cellectis to Report First Quarter Financial Results on May 11, 2026

Indeterminate GlobeNewswire
Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026
May 4, 2026

Cellectis publiera ses résultats financiers du premier trimestre le 11 mai 2026

Indeterminate GlobeNewswire
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 4, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Microvast Schedules First Quarter Earnings Call
May 4, 2026

Microvast Schedules First Quarter Earnings Call

Indeterminate GlobeNewswire
Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program
May 4, 2026

Opus Genetics Announces FDA Acceptance of OPGx-LCA5 into Rare Disease Evidence Principles (RDEP) Program

Indeterminate GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
May 4, 2026

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

Indeterminate GlobeNewswire
BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026
May 4, 2026

BioAge to Host R&D Day Focused on NLRP3 Inhibition on May 8, 2026

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Nevada Tech Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.